Información del artículo
El Texto completo está disponible en PDF
Complementos
[Kollef, 2004]
M.H. Kollef.
Prevention of hospital-associated pneumonia and ventilator-associated pneumonia.
Crit Care Med., 32 (2004), pp. 1396-1405
[Vriesendorp, 2006]
F.J. Vriesendorp.
Pathogenesis of Guillain-Barré syndrome in adults.
UpToDate, (2006),
Bibliografía
[1.]
Miller A. Guillain-Barré syndrome. http://www.emedicine.com/emerg/topic222.htm.
[2.]
S.B. Atkinson, R.B. Carr, P. Maybee, D. Haynes.
The challenges of managing and treating Guillain-Barré syndrome during the acute phase.
Dimens Crit Care Nurs, 25 (2006), pp. 256-263
[3.]
D.L. Newswanger, C.R. Warren.
Guillain-Barré syndrome.
Am Fam Physician, 610 (2004), pp. 2405-2410
[4.]
L.L. Sulton.
Meeting the challenge of Guillain- Barré syndrome.
Nurs Manage, 33 (2002), pp. 25-30
[5.]
Davids HR. Guillain-Barré syndrome. http://www.emedicine.com/pmr/topic49.htm.
[6.]
J.V. Hickey.
The Clinical Practice of Neurological & Neurosurgical Nursing.
6th, Lippincott Williams & Wilkins, (2008),
[7.]
R.A. Hughes, A.V. Swan, R. Van Koningsveld, P.A. van Doorn.
Corticosteroids for Guillain-Barré syndrome.
Cochrane Library, (2006), pp. 4
[8.]
R.A. Hughes, E.F. Wijdicks, R. Barohn, et al.
Practice parameter: immunotherapy for Guillain-Barré syndrome: report of the Quality Standards Subcommittee of the American Academy of Neurology.
Neurology, 61 (2003), pp. 736-740
[9.]
F.J. Vriesendorp.
Treatment and prognosis of Guillain-Barré syndrome in adults.
UpToDate, (2006),
[10.]
Institute for Healthcare Improvement. 5 Million Lives Campaign. http://www.ihi.org/IHI/Programs/Campaign/Campaign.htm?TabId=2.
[11.]
R.A. Hughes, E.M. Wijdicks, E. Benson, et al.
Supportive care for patients with Guillain-Barré syndrome.
Arch Neurol, 62 (2005), pp. 1194-1198
Copyright © 2010. Lippincott Williams & Wilkins
Opciones de artículo